Post Doctor at Cancer Targeting Treatment , Shenzhen Institute of Advanced Technology, China
๐จโ๐He remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.
๐ฌ He successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.
๐ The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.
Professional Profiles:
Education:
Mr. Liang Gong pursued his education in biotechnology, earning a Ph.D. from Jiangnan University in Wuxi, Jiangsu, CN (2019-09-06 to 2023-06-13) from the School of Biotechnology. Prior to this, he obtained an MD from Hunan Normal University in Changsha, Hunan, CN (2016-09 to 2019-06) with a focus on the State Key Laboratory of Developmental Biology of Freshwater Fish, Hunan Provincial Key Laboratory of Microbial Molecular Biology, College of Life Science. ๐
Patent & Funding:
Mr. Liang Gong is the inventor of the patent “Ligand-Targeted Cell Conjugate (Ltcc)-Based Anti-Tumor Immune Cell, As Well As Preparation Method And Use Thereof” with the registration number US 17551412. Additionally, he has received funding from the Postgraduate Research and Practice Innovation Program of Jiangsu Province (KYCX21_2021).
Publications:
Reprogramming tumor-associated macrophages by a dually targeted milk exosome system as a potent monotherapy for cancer
An off-the-shelf small extracellular vesicle nanomedicine for tumor targeting therapy
ELOA promotes tumor growth and metastasis by activating RBP1 in gastric cancer
EXOSC8 promotes colorectal cancer tumorigenesis via regulating ribosome biogenesis-related processes
A novel high-risk subpopulation identified by CTSL and ZBTB7B in gastric cancer
Hyaluronic Acid-Coated Bovine Milk Exosomes for Achieving Tumor-Specific Intracellular Delivery of miRNA-204
Ferroptosis-Associated Molecular Features to Aid Patient Clinical Prognosis and Therapy Across Human Cancers
ฮฒ-Galactosidase-dependent metabolic glycoengineering of tumor cells for imaging and immunotherapy
Chemical Synthesis of Antibody-Hapten Conjugates Capable of Recruiting the Endogenous Antibody to Magnify the Fc Effector Immunity of Antibody for Cancer Immunotherapy
Chemoenzymatic Synthesis of a Rhamnose-Functionalized Bispecific Nanobody as a Bispecific Antibody Mimic for Cancer Immunotherapy